US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Capstone Therapeutics Corp

0.1850

+0.00191.04%

Post-market: 0.19000.0050+2.70%17:16 EDT

Volume:114.15K

Turnover:21.46K

Market Cap:3.81M

PE:-0.08

High:0.1941

Open:0.1842

Low:0.1824

Close:0.1831

52wk High:1.57

52wk Low:0.1716

Shares:20.58M

Float Shares:11.63M

Volume Ratio:0.48

T/O Rate:0.98%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.4235

EPS(LYR):-4.1220

ROE:-114.21%

ROA:-3.47%

PB:0.31

PE(LYR):-0.04

Loading ...

Overview Company News Filings

Capstone Holding Corp: Business Momentum in April and May Indicates That End-Market Conditions Have Improved Materially

THOMSON REUTERS

Capstone Reports Q1 2026 Results: Revenue up 60%, Gross Profit up 124%, Best Q1 Gross Margin in Four Years

THOMSON REUTERS

Press Release: Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years

Capstone net loss widens to $1.92 million in Q1 FY26; net sales rise 60% to $12.64 million

Capstone Holding delays Q1 10-Q filing, targets May 20 release

Capstone Holding Corp - Expects Positive Ebitda Run-Rate Beginning in Q2 FY2026

THOMSON REUTERS

Capstone Publishes Investor Faq Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance

THOMSON REUTERS

Capstone reaffirms FY2026 revenue outlook at $72.1 million, EBITDA at $3.8 million

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

Capstone Announces Investor Faq Focused on 2026 Guidance and Earnings

THOMSON REUTERS

Press Release: Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings

Capstone Therapeutics cuts conversion price to $0.57 on $500,000 of note principal

Capstone Holding Q4 Adj. EPS $(1.00) Misses $(0.13) Estimate, Sales $12.762M Miss $12.801M Estimate

Benzinga Earnings

Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4X Ebitda Growth in 2026

THOMSON REUTERS

Capstone Holding Corp - FY2026 Guidance Calls for $72.1 Mln Revenue, $18.7 Mln Gross Profit, Positive Ebitda Run-Rate in Q2

THOMSON REUTERS

Press Release: Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026

Capstone posts FY25 net loss of $21.2 million; net sales rise 4% to $46.9 million

Capstone Is Said to Tap Scotiabank to Divest Mexican Copper Mine - Bloomberg News

THOMSON REUTERS

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Capstone wins Eldorado Stone distribution rights, targets $5 million annual run-rate revenue by Q3 2027

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CAPS/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CAPS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAPS\",,,,,undefined,":{"symbol":"CAPS","market":"US","secType":"STK","nameCN":"Capstone Therapeutics Corp","latestPrice":0.185,"timestamp":1788206400000,"preClose":0.1831,"halted":0,"volume":114153,"hourTrading":{"tag":"盘后","latestPrice":0.19,"preClose":0.185,"latestTime":"17:16 EDT","volume":396,"amount":75.4121016,"timestamp":1788210970871,"change":0.005,"changeRate":0.027027,"amplitude":0.036216},"delay":0,"changeRate":0.010376843255051801,"floatShares":11632600,"shares":20578600,"eps":-2.42352,"marketStatus":"Post-Mkt","change":0.0019,"latestTime":"08-31 17:25:59 EDT","open":0.1842,"high":0.1941,"low":0.1824,"amount":21456.52778217,"amplitude":0.0639,"askPrice":0.1949,"askSize":867,"bidPrice":0.1851,"bidSize":169,"shortable":3,"etf":0,"ttmEps":-2.42352,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788220800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1831,"preHourTrading":{"tag":"盘前","latestPrice":0.1875,"preClose":0.1831,"latestTime":"08:59 EDT","volume":5021,"amount":953.5807884999999,"timestamp":1788181197868,"change":0.0044,"changeRate":0.024031,"amplitude":0.081922},"postHourTrading":{"tag":"盘后","latestPrice":0.19,"preClose":0.185,"latestTime":"17:16 EDT","volume":396,"amount":75.4121016,"timestamp":1788210970871,"change":0.005,"changeRate":0.027027,"amplitude":0.036216},"volumeRatio":0.478499},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CAPS\",,,,,undefined,":{"symbol":"CAPS","floatShares":11632600,"roa":"-3.47%","roe":"-114.21%","lyrEps":-4.121993,"volumeRatio":0.478499,"shares":20578600,"dividePrice":0,"high":0.1941,"amplitude":0.0639,"preClose":0.1831,"low":0.1824,"week52Low":0.171601,"pbRate":"0.31","psRate":"0.06","week52High":1.57,"institutionHeld":0.0038,"latestPrice":0.185,"committee":-0.673745,"eps":-2.42352,"divideRate":0,"volume":114153,"delay":0,"ttmEps":-2.42352,"open":0.1842,"prevYearClose":0.7279,"prevWeekClose":0.1831,"prevMonthClose":0.253,"prevQuarterClose":0.254,"fiveDayClose":0.1882,"twentyDayClose":0.2511,"sixtyDayClose":0.3345},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CAPS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"CAPS","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-04-01","symbol":"CAPS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743480000000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2020-08-05","symbol":"CAPS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1596600000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-05-07","symbol":"CAPS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1588824000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-02-07","symbol":"CAPS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1581051600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CAPS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CAPS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1743739200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CAPS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CAPS","date":"2026-08-28","current":-0.076335,"percent":0.889189,"low":-5.872699,"twenty":-2.890731,"median":-1.299483,"eighty":-0.205012,"high":-0.124905,"avg":-1.696058,"sd":1.324433,"marketCap":3807031},"quantilePoints":[{"date":"2025-03-05","current":-5.669144,"twenty":-5.669144,"median":-5.669144,"eighty":-5.669144,"marketCap":19722953},{"date":"2025-03-14","current":-3.759538,"twenty":-4.953042,"median":-4.565153,"eighty":-4.47564,"marketCap":13079432},{"date":"2025-03-21","current":-3.177705,"twenty":-4.639747,"median":-4.445803,"eighty":-3.311974,"marketCap":11055234},{"date":"2025-03-28","current":-3.7297,"twenty":-4.490559,"median":-4.154886,"eighty":-3.311974,"marketCap":12975627},{"date":"2025-04-04","current":-4.212143,"twenty":-4.639747,"median":-4.177264,"eighty":-3.580512,"marketCap":10795722},{"date":"2025-04-11","current":-4.897426,"twenty":-4.779162,"median":-4.194704,"eighty":-3.595431,"marketCap":12552103},{"date":"2025-04-17","current":-4.4349,"twenty":-4.908549,"median":-4.395595,"eighty":-3.667586,"marketCap":11366649},{"date":"2025-04-25","current":-4.151391,"twenty":-4.835216,"median":-4.177264,"eighty":-3.720885,"marketCap":10640014},{"date":"2025-05-02","current":-3.84763,"twenty":-4.787262,"median":-4.121698,"eighty":-3.720885,"marketCap":9861476},{"date":"2025-05-09","current":-3.564121,"twenty":-4.746761,"median":-4.110889,"eighty":-3.602784,"marketCap":9134841},{"date":"2025-05-16","current":-3.361614,"twenty":-4.65953,"median":-4.080514,"eighty":-3.577234,"marketCap":8615816},{"date":"2025-05-23","current":-3.119377,"twenty":-4.520397,"median":-4.001295,"eighty":-3.54387,"marketCap":9913379},{"date":"2025-05-30","current":-2.939727,"twenty":-4.481608,"median":-3.888131,"eighty":-3.392655,"marketCap":9342451},{"date":"2025-06-06","current":-3.103045,"twenty":-4.457738,"median":-3.783334,"eighty":-3.204302,"marketCap":9861476},{"date":"2025-06-13","current":-3.037717,"twenty":-4.439261,"median":-3.7297,"eighty":-3.145507,"marketCap":9653866},{"date":"2025-06-20","current":-3.070381,"twenty":-4.403456,"median":-3.685625,"eighty":-3.125909,"marketCap":9757671},{"date":"2025-06-27","current":-2.776408,"twenty":-4.298631,"median":-3.589901,"eighty":-3.086713,"marketCap":8823426},{"date":"2025-07-03","current":-2.466104,"twenty":-4.205167,"median":-3.572317,"eighty":-3.070381,"marketCap":7837279},{"date":"2025-07-11","current":-2.335449,"twenty":-4.172089,"median":-3.54387,"eighty":-2.978923,"marketCap":7422058},{"date":"2025-07-18","current":-2.645754,"twenty":-4.147614,"median":-3.427983,"eighty":-2.897264,"marketCap":8408206},{"date":"2025-07-25","current":-2.61309,"twenty":-4.128184,"median":-3.311974,"eighty":-2.776408,"marketCap":8304401},{"date":"2025-08-01","current":-2.711081,"twenty":-4.110889,"median":-3.201036,"eighty":-2.727413,"marketCap":8615816},{"date":"2025-08-08","current":-2.1558,"twenty":-4.110889,"median":-3.168372,"eighty":-2.645754,"marketCap":6851131},{"date":"2025-08-15","current":-2.106804,"twenty":-4.106839,"median":-3.135708,"eighty":-2.606557,"marketCap":6695423},{"date":"2025-08-22","current":-1.611958,"twenty":-4.090639,"median":-3.119377,"eighty":-2.482436,"marketCap":5637017},{"date":"2025-08-29","current":-1.947118,"twenty":-4.086589,"median":-3.094879,"eighty":-2.439973,"marketCap":6809070},{"date":"2025-09-05","current":-1.819438,"twenty":-4.070388,"median":-3.078547,"eighty":-2.351781,"marketCap":6362573},{"date":"2025-09-12","current":-2.010957,"twenty":-4.050137,"median":-3.070381,"eighty":-2.286454,"marketCap":7032318},{"date":"2025-09-19","current":-2.425917,"twenty":-4.001295,"median":-3.021386,"eighty":-2.221127,"marketCap":8483431},{"date":"2025-09-26","current":-2.042877,"twenty":-3.888131,"median":-2.939727,"eighty":-2.122677,"marketCap":7143942},{"date":"2025-10-03","current":-2.234397,"twenty":-3.888131,"median":-2.915229,"eighty":-2.090757,"marketCap":7813687},{"date":"2025-10-10","current":-1.947118,"twenty":-3.84763,"median":-2.874399,"eighty":-2.042877,"marketCap":6809070},{"date":"2025-10-17","current":-1.98365,"twenty":-3.807129,"median":-2.776408,"eighty":-2.042877,"marketCap":6936825},{"date":"2025-10-24","current":-2.127916,"twenty":-3.759538,"median":-2.729156,"eighty":-2.041477,"marketCap":7441321},{"date":"2025-10-31","current":-1.821352,"twenty":-3.7297,"median":-2.719247,"eighty":-2.010957,"marketCap":6369267},{"date":"2025-11-07","current":-1.699447,"twenty":-3.7297,"median":-2.645754,"eighty":-1.98365,"marketCap":5942967},{"date":"2025-11-14","current":-1.857418,"twenty":-3.704256,"median":-2.621256,"eighty":-1.947584,"marketCap":6495391},{"date":"2025-11-21","current":-0.899928,"twenty":-3.685625,"median":-2.604924,"eighty":-1.947118,"marketCap":4990100},{"date":"2025-11-28","current":-1.367416,"twenty":-3.620823,"median":-2.566034,"eighty":-1.909062,"marketCap":7582319},{"date":"2025-12-05","current":-1.288548,"twenty":-3.597269,"median":-2.466104,"eighty":-1.893484,"marketCap":7144997},{"date":"2025-12-12","current":-1.258289,"twenty":-3.586583,"median":-2.43448,"eighty":-1.873824,"marketCap":6977212},{"date":"2025-12-19","current":-1.061906,"twenty":-3.581284,"median":-2.425596,"eighty":-1.848963,"marketCap":5888268},{"date":"2025-12-26","current":-1.101003,"twenty":-3.570677,"median":-2.384445,"eighty":-1.839385,"marketCap":6105060},{"date":"2026-01-02","current":-1.090367,"twenty":-3.564121,"median":-2.327284,"eighty":-1.820204,"marketCap":6046086},{"date":"2026-01-09","current":-1.03719,"twenty":-3.556021,"median":-2.286454,"eighty":-1.793902,"marketCap":5751216},{"date":"2026-01-16","current":-0.986408,"twenty":-3.54387,"median":-2.234397,"eighty":-1.741162,"marketCap":5469635},{"date":"2026-01-23","current":-1.056363,"twenty":-3.523619,"median":-2.221127,"eighty":-1.624117,"marketCap":5857535},{"date":"2026-01-30","current":-0.944316,"twenty":-3.436763,"median":-2.1558,"eighty":-1.367416,"marketCap":5236231},{"date":"2026-02-06","current":-0.875353,"twenty":-3.403002,"median":-2.125297,"eighty":-1.299633,"marketCap":4853832},{"date":"2026-02-13","current":-0.832085,"twenty":-3.351686,"median":-2.106717,"eighty":-1.255892,"marketCap":4613913},{"date":"2026-02-20","current":-0.964019,"twenty":-3.311974,"median":-2.090757,"eighty":-1.21335,"marketCap":5345486},{"date":"2026-02-27","current":-1.098248,"twenty":-3.267217,"median":-2.05731,"eighty":-1.173654,"marketCap":6089783},{"date":"2026-03-06","current":-0.970247,"twenty":-3.217368,"median":-2.042877,"eighty":-1.134557,"marketCap":5380020},{"date":"2026-03-13","current":-1.04613,"twenty":-3.184704,"median":-2.042177,"eighty":-1.116432,"marketCap":5800789},{"date":"2026-03-20","current":-1.29115,"twenty":-3.177705,"median":-2.025145,"eighty":-1.116432,"marketCap":7159426},{"date":"2026-03-27","current":-1.073992,"twenty":-3.168372,"median":-2.00632,"eighty":-1.116432,"marketCap":5955283},{"date":"2026-04-02","current":-0.95058,"twenty":-3.155306,"median":-1.99834,"eighty":-1.101003,"marketCap":5270966},{"date":"2026-04-10","current":-0.888301,"twenty":-3.138974,"median":-1.98365,"eighty":-1.088075,"marketCap":4925627},{"date":"2026-04-17","current":-0.228802,"twenty":-3.135708,"median":-1.955331,"eighty":-1.061337,"marketCap":4857468},{"date":"2026-04-24","current":-0.224219,"twenty":-3.135708,"median":-1.947118,"eighty":-1.053427,"marketCap":4760160},{"date":"2026-05-01","current":-0.210461,"twenty":-3.122643,"median":-1.938334,"eighty":-1.044794,"marketCap":4468091},{"date":"2026-05-08","current":-0.205012,"twenty":-3.106311,"median":-1.911518,"eighty":-1.036336,"marketCap":4352408},{"date":"2026-05-15","current":-0.15964,"twenty":-3.103045,"median":-1.899237,"eighty":-1.012754,"marketCap":3389151},{"date":"2026-05-22","current":-0.223309,"twenty":-3.089979,"median":-1.893484,"eighty":-0.99493,"marketCap":4782615},{"date":"2026-05-29","current":-0.179865,"twenty":-3.086713,"median":-1.883277,"eighty":-0.983081,"marketCap":3852163},{"date":"2026-06-05","current":-0.197197,"twenty":-3.076914,"median":-1.867317,"eighty":-0.970247,"marketCap":4223365},{"date":"2026-06-12","current":-0.177742,"twenty":-3.070381,"median":-1.851357,"eighty":-0.955366,"marketCap":3806710},{"date":"2026-06-18","current":-0.173321,"twenty":-3.070381,"median":-1.839385,"eighty":-0.94645,"marketCap":3712016},{"date":"2026-06-26","current":-0.138598,"twenty":-3.057315,"median":-1.830369,"eighty":-0.919958,"marketCap":2968350},{"date":"2026-07-02","current":-0.16153,"twenty":-3.037717,"median":-1.820395,"eighty":-0.902264,"marketCap":3459497},{"date":"2026-07-10","current":-0.156048,"twenty":-3.031184,"median":-1.803478,"eighty":-0.895971,"marketCap":3342077},{"date":"2026-07-17","current":-0.151214,"twenty":-2.998521,"median":-1.786401,"eighty":-0.877648,"marketCap":3238544},{"date":"2026-07-24","current":-0.144316,"twenty":-2.965857,"median":-1.743448,"eighty":-0.836641,"marketCap":3090821},{"date":"2026-07-31","current":-0.141545,"twenty":-2.939727,"median":-1.699447,"eighty":-0.229937,"marketCap":3031479},{"date":"2026-08-07","current":-0.159231,"twenty":-2.939727,"median":-1.617563,"eighty":-0.224219,"marketCap":3410256},{"date":"2026-08-14","current":-0.124905,"twenty":-2.923395,"median":-1.367416,"eighty":-0.220766,"marketCap":2760022},{"date":"2026-08-21","current":-0.176944,"twenty":-2.907063,"median":-1.344871,"eighty":-0.212511,"marketCap":3909924},{"date":"2026-08-28","current":-0.172287,"twenty":-2.890731,"median":-1.299483,"eighty":-0.205012,"marketCap":3807031}],"updateTime":1788211559763},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CAPS\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2636684148","title":"Capstone Holding Corp: Business Momentum in April and May Indicates That End-Market Conditions Have Improved Materially","url":"https://stock-news.laohu8.com/highlight/detail?id=2636684148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636684148?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:35","pubTimestamp":1779276900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUATFM4F:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","BK4139","CAPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636184162","title":"Capstone Reports Q1 2026 Results: Revenue up 60%, Gross Profit up 124%, Best Q1 Gross Margin in Four Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2636184162","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636184162?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:35","pubTimestamp":1779276900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUATFM4F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CAPS","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636841915","title":"Press Release: Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2636841915","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636841915?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:35","pubTimestamp":1779276900,"startTime":"0","endTime":"0","summary":"Gross margin expanded 670 bps to 23.5% against one of the harshest winters in recent memory for seasonal businesses. Capstone Holding Corp. , a tech-enabled building products distribution platform, today reported financial and operating results for the first quarter of 2026. Q1 revenue grew 60% year-over-year to $12.6 million, gross profit grew 124% to $3.0 million, and gross margin expanded 670 basis points to 23.5%--the strongest first-quarter gross margin Capstone has reported in four years. Results reflect the first full quarter of contribution from Carolina Stone and Canadian Stone Industries .On a pro-forma basis, giving effect to the Carolina Stone and CSI acquisitions as if they had been owned for all of FY2025, platform revenue would have been approximately $68 million, compared with $46.9 million as reported. Business momentum in April and May indicates that end-market conditions have improved materially, and Capstone reaffirms FY2026 guidance of $72.1 million in revenue , $1","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"Press Release: Capstone Reports Q1 2026 Results: Revenue Up 60%, Gross Profit Up 124%, Best Q1 Gross Margin in Four Years","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636841630","title":"Capstone net loss widens to $1.92 million in Q1 FY26; net sales rise 60% to $12.64 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2636841630","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636841630?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:32","pubTimestamp":1779276745,"startTime":"0","endTime":"0","summary":"Capstone Therapeutics posted a net loss of $1.92 million for the quarter ended March 31, 2026, widening 11% from a year earlier.Net sales rose to $12.64 million, up 60%, while gross profit climbed to $2.97 million, up 124%.Gross margin improved to 23.5% from 16.8%, reflecting gains in the TotalStone segment and the addition of Carolina Stone, which carried a gross margin of about 37.8%.Operating loss widened to $1.5 million as selling, general and administrative expenses increased to $4.47 million, up 62%, while interest and other expense deepened to $892,000, up 197%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electroni","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL4Gvtgd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4104","CAPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635588970","title":"Capstone Holding delays Q1 10-Q filing, targets May 20 release","url":"https://stock-news.laohu8.com/highlight/detail?id=2635588970","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635588970?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:46","pubTimestamp":1778878017,"startTime":"0","endTime":"0","summary":"Capstone Therapeutics disclosed a delay in filing its Form 10-Q for quarter ended March 31, 2026, citing additional time needed to finalize quarterly financial statements and complete interim review.Filing now expected no later than May 20, 2026, alongside related investor materials.Notification of Late Filing on Form 12b-25 to be submitted to SEC.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief on May 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9ZZyn9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633027187","title":"Capstone Holding Corp - Expects Positive Ebitda Run-Rate Beginning in Q2 FY2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2633027187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633027187?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:35","pubTimestamp":1778067300,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUABSBRVK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4104","CAPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633025187","title":"Capstone Publishes Investor Faq Detailing 72% Reduction in Convertible Principal and Reaffirming FY2026 Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2633025187","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633025187?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:35","pubTimestamp":1778067300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nTUABSBRVK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAPS","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633187706","title":"Capstone reaffirms FY2026 revenue outlook at $72.1 million, EBITDA at $3.8 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2633187706","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633187706?lang=en_us&edition=fundamental","pubTime":"2026-05-06 19:33","pubTimestamp":1778067184,"startTime":"0","endTime":"0","summary":"Capstone Therapeutics reaffirmed FY2026 guidance for revenue of $72.1 million, up 54%, with gross profit of about $18.7 million, up 73%.Outlook also calls for EBITDA of about $3.8 million, implying roughly 322% year-over-year growth, with a positive EBITDA run-rate expected from Q2.Guidance follows progress on capital structure, with about 72% of $6.82 million original convertible-note principal converted as of May 1, leaving $1.9 million outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 06, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260506:nNDL3xqrkk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306743","title":"Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306743","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630306743?lang=en_us&edition=fundamental","pubTime":"2026-04-28 19:30","pubTimestamp":1777375800,"startTime":"0","endTime":"0","summary":"– ARCALYST (rilonacept) Q1 2026 net product revenue of $214.3 million, representing 56% year-over-year growth –– ARCALYST 2026 expected net product revenue increased to $930 - $945 million –– KPL-387 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/28/3282473/0/en/Kiniksa-Pharmaceuticals-Reports-First-Quarter-2026-Financial-Results-and-Recent-Portfolio-Execution.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","BK4139","CAPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629306035","title":"Capstone Announces Investor Faq Focused on 2026 Guidance and Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2629306035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629306035?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:30","pubTimestamp":1776771001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260421:nTUA5TVC1B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAPS","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629035524","title":"Press Release: Capstone Announces Investor FAQ Focused on 2026 Guidance and Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2629035524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629035524?lang=en_us&edition=fundamental","pubTime":"2026-04-21 19:30","pubTimestamp":1776771000,"startTime":"0","endTime":"0","summary":"Company invites shareholder submissions; FAQ to expand on growth trajectory, margin profile, and path to profitability. Capstone Holding Corp. , a tech-enabled building products distribution platform, will publish an investor FAQ during the week of May 4, addressing key questions from its shareholder base. The FAQ will provide additional detail on the Company's recent earnings and 2026 guidance, which includes 54% revenue growth and approximately 4x EBITDA growth.This press release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. These statements relate to future events and performance, including guidance regarding revenue and EBITDA targets, M&A strategy, use of capital, and operating outlook. Actual results may differ materially from those projected due to a range of factors, including but not limited to acquisition timing, macroeconomic conditions, and execution risks. Please review the Company's filings with the SEC for a full ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CAPS","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628455122","title":"Capstone Therapeutics cuts conversion price to $0.57 on $500,000 of note principal","url":"https://stock-news.laohu8.com/highlight/detail?id=2628455122","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628455122?lang=en_us&edition=fundamental","pubTime":"2026-04-17 03:10","pubTimestamp":1776366610,"startTime":"0","endTime":"0","summary":"Capstone Therapeutics reduced conversion price on $500,000 principal of October 2025 Convertible Note to $0.57 under voluntary adjustment notice dated April 16, 2026.October 2025 Convertible Note principal balance stood at $1.9 million as of April 16, 2026.Company previously registered 8,388,336 shares for issuance on conversion of senior secured convertible notes under Form S-1 registration statements.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on April 16, 2026, and is solely responsible for the informati","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDLb8d8xx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627974022","title":"Capstone Holding Q4 Adj. EPS $(1.00) Misses $(0.13) Estimate, Sales $12.762M Miss $12.801M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2627974022","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627974022?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:45","pubTimestamp":1776339917,"startTime":"0","endTime":"0","summary":"Capstone Holding (NASDAQ:CAPS) reported quarterly losses of $(1.00) per share which missed the analyst consensus estimate of $(0.13) by 669.23 percent.  The company reported quarterly sales of $12.762 million which","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51853436/capstone-holding-q4-adj-eps-1-00-misses-0-13-estimate-sales-12-762m-miss-12-801m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627813297","title":"Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4X Ebitda Growth in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627813297","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627813297?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:30","pubTimestamp":1776339001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA3Q1F59:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAPS","BK4139","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627297865","title":"Capstone Holding Corp - FY2026 Guidance Calls for $72.1 Mln Revenue, $18.7 Mln Gross Profit, Positive Ebitda Run-Rate in Q2","url":"https://stock-news.laohu8.com/highlight/detail?id=2627297865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627297865?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:30","pubTimestamp":1776339001,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nTUA3Q1F59:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4104","CAPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627318297","title":"Press Release: Capstone Reports FY2025 Results and Guides to 54% Revenue Growth and 4x EBITDA Growth in 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2627318297","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627318297?lang=en_us&edition=fundamental","pubTime":"2026-04-16 19:30","pubTimestamp":1776339000,"startTime":"0","endTime":"0","summary":"FY2025 gross margin expands to 23% on $46.9M revenue; FY2026 guidance calls for $72.1M of revenue, $18.7M of gross profit , and a positive EBITDA run-rate starting in Q2. Capstone Holding Corp. , a tech-enabled building products distribution platform, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025.The Company closed FY2025 with $46.9 million in revenue and gross margin expanding to 23.0%, reflecting acquisition-driven scale and a higher-margin product mix. For FY2026, Capstone expects revenue to rise 54% to $72.1 million, gross margin to reach 26%, and EBITDA to increase more than fourfold to approximately $3.8 million, driven by operating leverage, product expansion, and geographic expansion.\"It was a transformational year for Capstone,\" said Matthew Lipman, Chief Executive Officer. \"Synergies from our recent acquisitions are enabling margin growth and operating leverage across the platform. With a full year of contribution","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4104","CAPS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627299649","title":"Capstone posts FY25 net loss of $21.2 million; net sales rise 4% to $46.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627299649","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627299649?lang=en_us&edition=fundamental","pubTime":"2026-04-16 18:04","pubTimestamp":1776333899,"startTime":"0","endTime":"0","summary":"Capstone Therapeutics posted a net loss of USD 21.2 million for fiscal 2025, widening from USD 2.6 million.Net sales rose 4% to USD 46.9 million.Operating loss widened to USD 11 million, reflecting a USD 6.2 million goodwill impairment charge.Selling, general and administrative expenses jumped 41% to USD 14.4 million, driven by acquisition-related operating costs and higher public company costs.Management said it expects existing cash, revolving credit availability, and operating cash flow to fund operations for at least the next 12 months while it evaluates refinancing or extensions for debt maturities in 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to gener","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260416:nNDL8dHtr9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626725137","title":"Capstone Is Said to Tap Scotiabank to Divest Mexican Copper Mine - Bloomberg News","url":"https://stock-news.laohu8.com/highlight/detail?id=2626725137","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626725137?lang=en_us&edition=fundamental","pubTime":"2026-04-10 03:59","pubTimestamp":1775764747,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nFWN40S0WE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CAPS","BK4104","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625949489","title":"Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis","url":"https://stock-news.laohu8.com/highlight/detail?id=2625949489","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625949489?lang=en_us&edition=fundamental","pubTime":"2026-04-08 20:00","pubTimestamp":1775649600,"startTime":"0","endTime":"0","summary":"– Educational campaign to raise awareness of recurrent pericarditis and to empower patients to discuss ARCALYST with their healthcare provider – – Media accompanying this announcement is available by ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/04/08/3270058/0/en/Kiniksa-Pharmaceuticals-Launches-Targeted-Direct-To-Consumer-TV-Campaign-for-ARCALYST-rilonacept-in-Recurrent-Pericarditis.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4100","BK4115","TV","CAPS","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625676445","title":"Capstone wins Eldorado Stone distribution rights, targets $5 million annual run-rate revenue by Q3 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2625676445","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625676445?lang=en_us&edition=fundamental","pubTime":"2026-04-06 19:30","pubTimestamp":1775475045,"startTime":"0","endTime":"0","summary":"Capstone secured distribution rights for Westlake Royal’s Eldorado Stone manufactured stone veneer brand.Management expects Eldorado Stone to add $5 million in annualized run-rate revenue by Q3 2027.Product will be sold through existing distribution channels, with no incremental infrastructure investment.Award expands Capstone’s relationship with Westlake Royal, where it already ranks as a top-three national distributor for Cultured Stone.Company targets positive corporate EBITDA run-rate beginning in Q2 2026, supported by Eldorado contribution and ongoing cost actions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Capstone Therapeutics Corporation published the original content used to generate this news brief via Business Wire  on A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260406:nNDLLgx7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAPS","WLK","BK4104","BK4139","BK4090"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":67,"code":"91000000","status":"200"}]}}